Prevention of persistent pain with LidocAine iNfusions in breast cancer surgery (PLAN): a multicentre randomized controlled trial

在乳腺癌手术 (PLAN) 中使用利多卡因输注预防持续性疼痛：一项多中心随机对照试验

• 批准号: 421155
• 负责人: Khan James S
• 金额: $ 93.63万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-03-01 至 2024-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=421155&lang=en
• 关键词: Breast Cancer Surgery; Intraoperative Infusion; Lidocaine; Persistent Pain; Prevention; Randomized Controlled Trial

Advances in screening and management have improved the lifespan of those diagnosed with breast cancer. However, since patients are living longer, complications of breast cancer management have become increasingly apparent. Chronic pain is a devastating co

筛查和治疗方面的进步提高了被诊断为乳腺癌的人的寿命。然而，随着患者寿命的延长，乳腺癌治疗的并发症也变得越来越明显。慢性疼痛是一种毁灭性的疾病